Aproviso And Vista Clinical Announce Next-Generation Clinical Trial Automation System

RICHBORO, Pa.--(BUSINESS WIRE)--June 16, 2005--Aproviso, Inc., a provider of secure, validated technologies for the life science and health care industries, and Vista Clinical, Inc., the leading innovator of clinical trial automation technology, announced today that they have formed a strategic partnership to deliver next-generation clinical trial automation technologies to the pharmaceutical, biotechnology and medical device industries. The business arrangement combines validation, hosting, deployment and support services provided by Aproviso with a new, next-generation clinical trial automation platform developed by Vista Clinical. The combination delivers the most powerful technology available under an independent certification (validation) together with a customer-centric focus on deployment and support.